The Cigna Group (NYSE:CI) Receives $373.69 Consensus Target Price from Analysts

Shares of The Cigna Group (NYSE:CI) have received an average recommendation of “Buy” from the seventeen analysts that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $373.69.

A number of equities analysts recently weighed in on CI shares. Oppenheimer lowered their price target on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a research report on Friday, January 31st. Barclays lowered their price target on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. StockNews.com lowered shares of The Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, January 31st. Cantor Fitzgerald decreased their target price on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Finally, Sanford C. Bernstein lowered shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 target price on the stock. in a report on Thursday, February 6th.

Institutional Investors Weigh In On The Cigna Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. TCTC Holdings LLC purchased a new stake in The Cigna Group during the 4th quarter worth approximately $25,000. Collier Financial purchased a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $32,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $34,000. Ulland Investment Advisors LLC increased its position in shares of The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Finally, Prospera Private Wealth LLC purchased a new stake in shares of The Cigna Group in the 3rd quarter valued at approximately $37,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Stock Performance

CI opened at $299.99 on Friday. The firm has a market capitalization of $83.44 billion, a PE ratio of 24.51, a PEG ratio of 0.94 and a beta of 0.54. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The firm’s 50-day moving average price is $287.42 and its 200 day moving average price is $321.61. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the business earned $6.79 EPS. As a group, sell-side analysts expect that The Cigna Group will post 29.8 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.01%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date of this dividend is Wednesday, March 5th. The Cigna Group’s payout ratio is 45.75%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.